Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis. FE [Internet]. 2018 Nov. 30 [cited 2025 Oct. 29];19(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1385